67 related articles for article (PubMed ID: 34187402)
1. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
[TBL] [Abstract][Full Text] [Related]
4. Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
Zhang JJ; Yu GZ; Zheng ZH; Liu YF; Du YY; Quan SX; Liu YJ; Lv JC; Zhang H
PLoS One; 2017; 12(4):e0175828. PubMed ID: 28414748
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy.
Luo R; Qian D; Yang D; Cheng Y; Li J; Liu L; Li Y; Lei Q; Chang X; Liu Y; Xu G; Ge S
Clin Chim Acta; 2024 Apr; 557():117888. PubMed ID: 38527714
[TBL] [Abstract][Full Text] [Related]
6. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
[TBL] [Abstract][Full Text] [Related]
7. External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients.
Zhang Q; Zhang Q; Duan Z; Chen P; Chen JJ; Li MX; Zhang JJ; Huo YH; Zhang WX; Yang C; Zhang Y; Chen X; Cai G
Clin Interv Aging; 2024; 19():911-922. PubMed ID: 38799377
[TBL] [Abstract][Full Text] [Related]
8. Haemoglobin, albumin, lymphocyte, and platelet score as an independent predictor for renal prognosis in IgA nephropathy.
Yuan Y; Liang X; He M; Wu Y; Jiang X
Front Endocrinol (Lausanne); 2024; 15():1339921. PubMed ID: 38737556
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid in IgA nephropathy with moderate proteinuria: A retrospective cohort study.
Wang Y; Yu J; Jiang Y; Li J; Yimamuyushan A; Xia X; Fan L; Huang F; Chen W; Liu Q
Nephrology (Carlton); 2024 May; 29(5):268-277. PubMed ID: 38186010
[TBL] [Abstract][Full Text] [Related]
10. Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.
Yuan Y; Wang Q; Ni Z; Che X; Cao L; Shao X; Zhang M; Xie Y; Qi C; Zhou W; Tian L; Mou S
J Transl Med; 2015 Jun; 13():186. PubMed ID: 26048044
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy.
Toal M; Fergie R; Quinn M; Hill C; O'Neill C; Maxwell AP
Syst Rev; 2024 May; 13(1):122. PubMed ID: 38704598
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes in IgA Nephropathy.
Pitcher D; Braddon F; Hendry B; Mercer A; Osmaston K; Saleem MA; Steenkamp R; Wong K; Turner AN; Wang K; Gale DP; Barratt J
Clin J Am Soc Nephrol; 2023 Jun; 18(6):727-738. PubMed ID: 37055195
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy versus supportive care in IgA nephropathy patients with stage 3 and 4 chronic kidney disease.
Ștefan G; Stancu S; Zugravu A; Petre N; Secăreanu S; Popa O; Capusa C
Medicine (Baltimore); 2022 Sep; 101(36):e30422. PubMed ID: 36086774
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of IgA Nephropathy with Stage 3b-5 CKD.
Wu Z; Li H; Liu Y; Wang F; Xing Y; Li W; Jia J; Yan T
Kidney Blood Press Res; 2024 Apr; ():. PubMed ID: 38565098
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Status and Clinical Outcomes in IgA Nephropathy.
Gao MZ; Xu LL; Li Y; Wang X; Chen P; Shi SF; Liu LJ; Lv JC; Hong FY; Zhang H; Zhou XJ
Kidney Int Rep; 2024 Apr; 9(4):1057-1066. PubMed ID: 38765575
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1.
Bi X; Yu Y; Zhou S; Zhou Y; Zhao J; Xiong J
Nephron; 2024 May; ():. PubMed ID: 38723614
[TBL] [Abstract][Full Text] [Related]
17. Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study.
Jiang Y; Chen P; Zhao W; Liu L; Shi S; Lv J; Zhang H
Front Med (Lausanne); 2024; 11():1344219. PubMed ID: 38439903
[TBL] [Abstract][Full Text] [Related]
18. Are children with IgA nephropathy different from adult patients?
Su B; Jiang Y; Li Z; Zhou J; Rong L; Feng S; Zhong F; Sun S; Zhang D; Xia Z; Feng C; Huang W; Li X; Chen C; Hao Z; Wang M; Qin L; Chen M; Li Y; Ding J; Bao Y; Liu X; Deng F; Cheng X; Zhang L; Zhang X; Yang H; Peng X; Sun Q; Deng L; Jiang X; Xie M; Gao Y; Yu L; Liu L; Gao C; Mao J; Zheng W; Dang X; Xia H; Wang Y; Zhong X; Ding J; Lv J; Zhang H
Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38578470
[TBL] [Abstract][Full Text] [Related]
19. Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy.
Xing Y; Yu H; Li H; Wang F; Wu Z; Li W; Liu Y; Jia J; Yan T
Heliyon; 2024 Apr; 10(7):e28509. PubMed ID: 38571652
[TBL] [Abstract][Full Text] [Related]
20. The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy.
Wei H; Liao B; Zhou Q; Zhou X; Zhong Y; Hao Y; Xie F; Wang R
Clin Exp Nephrol; 2024 May; ():. PubMed ID: 38767689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
